COVARYX is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Centrix Pharmaceutical, Inc,. The primary component is Estrogens, Esterified; Methyltestosterone.
| Product ID | 11528-010_9d03bf4c-e54a-795d-e053-2a95a90a9e02 |
| NDC | 11528-010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | COVARYX |
| Generic Name | Estrogens, Esterified And Methyltestosterone |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-04-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | CENTRIX PHARMACEUTICAL, INC, |
| Substance Name | ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE |
| Active Ingredient Strength | 1 mg/1; mg/1 |
| Pharm Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [CS] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2007-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-04-01 |
| Ingredient | Strength |
|---|---|
| ESTROGENS, ESTERIFIED | 1.25 mg/1 |
| SPL SET ID: | e4ff7b6b-ce78-402c-9c0e-b8b0d9636eae |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 11528-010 | COVARYX | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
| 11528-020 | COVARYX | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
| 15310-010 | EEMT | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
| 15310-020 | EEMT | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
| 66576-231 | SYNTEST D.S. | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
| 66576-230 | SYNTEST H.S. | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() COVARYX 76644307 3330071 Live/Registered |
Centrix Pharmaceutical, Inc. 2005-08-05 |